Prescription Sleeping Pill Use Tied To Cancer

div























Latest News For Cancer / Oncology
Bristol-Myers Squibb And PDL BioPharma Enter Global Alliance To Develop Novel Treatment For Multiple Myeloma
21 Aug 2008

Researcher Aims To 'Unmask' Cancer Cells To Trigger Body's Immune System
21 Aug 2008

New Insights Into The Regulation Of PTEN Tumor Suppressor Function
21 Aug 2008

View more news...

Latest Videos for Cancer
Monitoring and Adherence in CML



Imatinib, or Gleevec, is a targeted anticancer drug that can prevent chronic myelogenous leukemia (CML) in correspond for to the highest degree patients for many age. It is important for patients to take imatinib as prescribed by their doctor to fight the disease and to guard against immunity...


Treating Prostate Cancer Symptoms



Many men will have advanced prostate cancer without any noticeable symptoms. Treatment for these patients is a bit different than for other patients with prostate cancer. Learn about these differences...


View more videos...




Most Popular Categories

cancer �
cardiovascular �
dermatology �
hiv �
nutrition �

diabetes �
obesity �
pediatrics �
psychology �
neurology �
alcohol �

urology �
breast cancer �
women's health �
infectious diseases �
respiratory �
sexual health �

gastrointestinal �
pain �
pregnancy �
bones �
medical devices �
medicare �

depression �
prostate �
smoking �
alzheimer's �
allergy �
sleep �

biology �
genetics �
eye health �
sports medicine �
hypertension �
abortion �

health insurance �
autism �
stem cell research �
adhd �
liver disease �
multiple sclerosis �

arthritis �
pharma industry �
seniors �
dentistry �
it �
nursing �

blood �
fertility �

More info

• Depression link to poor driving
• Clipboards face hacking threat
• More women 40 to 44 remaining childless
• Body Type: Are You an Apple or a Pear?
• Most College Kids Have Thought of Suicide

U.S. NCI Starts Enrolment In Phase 2 Systemic Melanoma Clinical Trial With REOLYSIN(R)

�Oncolytics Biotech Inc.
("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced that the U.S.
National Cancer Institute (NCI), part of the National Institutes of Health,
has started enrollment in a Phase 2 clinical trial for patients with
metastatic melanoma using systemic presidency of REOLYSIN(R),
Oncolytics' proprietorship formulation of the human reovirus. The trial is
being carried out by the Mayo Phase 2 Consortium under the NCI's Clinical
Trials Agreement with Oncolytics, patch Oncolytics will provide clinical
supplies of REOLYSIN(R). The Principal Investigator is Dr. Evanthia Galanis
of the Mayo Clinic Cancer Center.



The basal objectives of the survey are to assess the antitumour
effects of REOLYSIN(R) in patients with metastatic malignant malignant melanoma, as
well as the safety profile of REOLYSIN(R). Secondary objectives include
assessment of patterned advance free survival of the fittest and boilersuit survival.



Patients will pick up systemic administration of REOLYSIN(R) at a dose
of 3x10(10) TCID(50) per day on days 15 of each 28 day cycle, and patients
may receive up to 12 cycles of treatment. The trial is expected to enroll
up to 47 patients with metastatic malignant melanoma.



Approximately 60,000 masses are diagnosed with malignant melanoma in the U.S.
every year.

About Oncolytics Biotech Inc.



Oncolytics is a Calgary-based biotechnology company focused on the
ontogenesis of oncolytic viruses as potential cancer therapeutics.
Oncolytics' clinical programme includes a variety of Phase I/II and Phase II
human trials victimisation REOLYSIN(R), its proprietary preparation of the human
reovirus, alone and in combination with radiation or chemotherapy. For
further information about Oncolytics, please visit
hTTP://www.oncolyticsbiotech.com



This press release contains advanced statements, inside the
significance of Section 21E of the Securities Exchange Act of 1934, as amended.
Forward-looking statements, including the Company's expectations related to
the U.S. NCI Phase 2 systemic administration clinical trial for patients
with metastatic malignant melanoma, and the Company's notion as to the potentiality of
REOLYSIN(R) as a cancer therapeutic, involve known and unknown risks and
uncertainties, which could cause the Company's actual results to disagree
materially from those in the innovative statements. Such risks and
uncertainties include, among others, the availableness of funds and
resources to go after research and development projects, the efficacy of
REOLYSIN(R) as a cancer discussion, the tolerability of REOLYSIN(R) outside
a controlled quiz, the success and seasonable completion of clinical studies
and trials, the Company's ability to successfully commercialize
REOLYSIN(R), uncertainties related to the enquiry and development of
pharmaceuticals and uncertainties related to the regulative process.
Investors should consult the Company's quarterly and annual filings with
the Canadian and U.S. securities commissions for additional entropy on
risks and uncertainties relating to the forward looking statements.
Investors ar cautioned against placing inordinate reliance on forward-looking
statements. The Company does non undertake to update these forward-looking
statements.


Oncolytics Biotech Inc.
http://www.oncolyticsbiotech.com



More info

• BRIDION(R) (sugammadex) Injection - First And Only Selective Relaxant Binding Agent - Approved In European Union
• ‘Some scream while others laugh’
• Cancer patients ‘left suicidal’
• Mobile health unit checks up on Ontario truckers
• ‘Tree Man’ To Head Home After Treatment

JDRF Announces 2008 Scholar Award Recipients

�
JDRF aforesaid on Friday (August 1, 2008) that it has recognized the work of two

Clementine Celarie

   
Artist: Clementine Celarie

   Genre(s): 
Ethnic
   

---

Discography:


   
 Family Groove

   Year: 2006   
Tracks: 15

---

 

Girlschool

   
Artist: Girlschool

   Genre(s): 
Metal
   Metal: Heavy
   Rock: Hard-Rock
   

---

Discography:


   
 Believe

   Year: 2004   
Tracks: 15


   
 Can't Keep A Good Girl Down

   Year: 1999   
Tracks: 16


   
 Live

   Year: 1996   
Tracks: 14


   
 Girlschool

   Year: 1992   
Tracks: 10


   
 Take A Bite

   Year: 1988   
Tracks: 10


   
 Nightmare At Maple Cross

   Year: 1986   
Tracks: 10


   
 Play Dirty

   Year: 1983   
Tracks: 10


   
 Screaming Blue Murder

   Year: 1982   
Tracks: 10


   
 Hit and Run

   Year: 1981   
Tracks: 11

---

Although the Runaways preceded them by several age, Girlschool was one of the first all-female outfits to emerge in the male-dominated domain of heavy metal/hard stone, serving to pave the way for similar groups of the future. Originally formed in South London during 1977 by bassist Enid Williams and vocalist/guitarist Kim McAuliffe (along with a few other members), the mathematical group was start known as Painted Lady. Eventually the couple came across lasting members Kelly Johnson (guitar, vocals) and Denise Dufort (drums), and switched their call to Girlschool by 1978. With England simply about to be swept up by a massive heavy metal move (known as the New Wave of British Heavy Metal), Girlschool picked a perfect time to consequence a debut undivided, "Take It All Away," which caught the attention of Motörhead handler Doug Smith, wHO in turn signed on as Girlschool's handler. After supporting both Motörhead and Budgie on circuit, Girlschool landed a recording contract with Bronze Records (wHO at the time was the plate to such notable metal acts as Motörhead, Uriah Heep, and Juicy Lucy).


The quartet's 1980 debut, Demolition, reached the U.K. Top 30, just was surprisingly non issued in the U.S. (despite spawning quatern popular singles back nursing home: "Emergency," "Nothing To Lose," "Yeah Right," and "Race With the Devil"). Girlschool's soph endeavour, 1981's Hit & Run, proven to be even more than successful, peaking at number five on the British album charts, while a coaction with their pals in Motörhead, an EP called The St. Valentines Day Massacre, pip numeral cinque on the British singles charts (due in constituent to the overpoweringly strident running, "Please Don't Touch"). Pip & Run would also turn forbidden to be the low Girlschool album issued stateside, albeit with a different data track itemization than the original U.K. version (the U.S. version was more or less a compiling of both of their albums). 1982's Screaming Blue Murder and 1983's Playact Dirty both failed to execute as imposingly on the U.K. charts as their predecessors did, the latter of which contained a more than commercial-grade sound and was produced by Slade members Noddy Holder and Jim Lea.


Just it was likewise more or less this sentence that card changes began to plague the mathematical group, starting off when Johnson left the radical undermentioned the release of Play Dirty. Further albums were issued (such as 1985's Linear Wild, 1986's Nightmare at Maple Cross, and 1988's Get hold of a Bite), just Girlschool was never able to replicate their early success, leading to their detachment curtly after the release of Take a Bite. In the arouse of Girlschool's initial split, McAuliffe teamed up with punk singers Beki Bondage and Toyah Willcox, worked on the U.K. cable's length television demonstrate Raw Power, and in 1991 toured with other bandmates Dufort and Williams below the name Strange Girls. Throughout the '90s, Girlschool would reunite sporadically for tours and albums (including 1992's self-titled release and 1995's Live), piece several compilations were issued, including 1995's double-disc best-of set The Collection and 1997's The King Biscuit Flower Hour Presents In Concert (the latter featuring a show recorded on January 12, 1984, in Nashville, TN).

Jack Black Busts Martial-Arts Moves At Fans' Request After 'Kung Fu Panda' Sneak Peek Week Screening

"You want me to do some kung fu?" Jack Black teased an excited audience member, who had stepped up to the mic looking for some real moves. "OK, just a taste."

The crowd came for a taste but wound up getting the full-course meal, complete with a kicking (and punching and twirling and jumping) dessert, as MTV's Sneak Peek Week continued with a screening of Black's "Kung Fu Panda" on Friday night at the Paramount Studios Lot.

The animated story of a panda waiter who winds up a master fighter was followed immediately after by a Q&A with Black himself.

"Important note," he added, sitting down after his demonstration and picking up his personal items from the table. "If someone's gonna fight you, remember to take out your wallet!"

Black's hands may be "fast as lightning," (when the heck did he take out his wallet?) but they were no match for his mouth, as audience members wanted to know everything from how much he was like Po the panda ("He's just a dreamer, a funny cuddly dreamer," Black said. "Like me!") to whether the actor would ever play a superhero (" 'Kung Fu Panda' is a superhero of sorts," he replied in mock indignation) to who would win in a fight between his characters from "Kung Fu Panda" and "Nacho Libre."

"My mind is bending around the concept of that one," Black laughed. "Because one is animated!"

One excited audience member, mildly flummoxed perhaps by that very concept, wanted to know if Black had used method acting to play a panda.

"I don't know if I did any panda preparations," Black answered, grinning. "I did not live with the pandas. I still have never seen a panda at a zoo. I just grew out my beard."

With his moves on such prominent display, however, talk inevitably turned to more pressing matters. And those matters were kicking butt and taking names (though not necessarily the second).

Since Black now was the lead voice in a kung fu movie, which martial-arts superstar does he like most?

"Stephen Chow. His movies are incredible," Black said. "I also really like Yang Chow. Unrelated. It's a restaurant."

The last questioner asked about his feelings on now being in the martial-arts fraternity.

"Am I part of it, do you think I will be? Makes me think I've really got to learn kung fu now," Black giggled, pausing briefly, perhaps thinking about his earlier demonstration. "For real!"

"Kung Fu Panda," which co-stars the voice talents of Angelina Jolie, Seth Rogen and Dustin Hoffman, opens nationwide June 6.

Check out everything we've got on "Kung Fu Panda."

For breaking news, celebrity columns, humor and more - updated around the clock - visit MTVMoviesBlog.com.

The MTV Movie Awards will air live on MTV on Sunday at 8 p.m. ET, with MTV News' "Coming Attractions" preshow kicking the evening off at 7:30 p.m. ET! Find all the latest updates on nominees, presenters, performers, voting, contests, movie exclusives and much more at MovieAwards.MTV.com. And check out Movies.MTV.com for the latest movie news, trailers, photos and more!






See Also

• Jack Nicholson - Actress Memoir Alleges Nicholsons Illicit Affairs With Prostitutes
• Graham Norton - Id Do Anything Girls Attempt To Build Bridges
• Ashley Olsen - Bad Neighbour Olsen Twins Selling New York Penthouse
• Anael And Bradfield

Actor Vin Diesel reveals that he's a dad

Actor Vin Diesel and his model girlfriend Paloma Jimenez are celebrating the birth of their first child together, a baby girl.
According to People magazine, Diesel's representative confirmed that the baby was born in April but the news has only become public now.
No details on the baby's weight at the time of her birth or her name were given.
Diesel is currently shooting 'Fast and Furious', which is due for release next summer.